Description
AOD9604 (Advanced Obesity Drug 9604)
AOD9604 is a synthetic hexadecapeptide fragment corresponding to the C-terminal region (amino acids 177–191) of human growth hormone (hGH), modified with an additional N-terminal tyrosine residue to enhance stability. Developed to isolate specific metabolic characteristics, this compound is widely utilized in laboratory research to investigate lipid pathways without initiating broader systemic growth or glycemic alterations. [1, 2, 3]
Product Specifications
Core Research Applications
-
- Adipocyte Lipolysis Signaling: Studied in vitro for its ability to selectively stimulate lipolysis (fat breakdown) and inhibit lipogenesis (the transformation of non-fat food into body fat). [1, 2]
- Receptor Specificity: Researched for its localized upregulation of β₃-adrenergic receptors and inhibition of lipoprotein lipase, bypassing IGF-1 receptor pathways entirely. [1, 2]
- Cartilage and Joint Biology: Frequently investigated in preclinical animal models to evaluate its effects on joint microenvironments and regenerative matrix structures. [, 2]
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reviews
There are no reviews yet.